Your browser doesn't support javascript.
International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020.
Matheeussen, Veerle; Corman, Victor M; Donoso Mantke, Oliver; McCulloch, Elaine; Lammens, Christine; Goossens, Herman; Niemeyer, Daniela; Wallace, Paul S; Klapper, Paul; Niesters, Hubert Gm; Drosten, Christian; Ieven, Margareta.
  • Matheeussen V; Department of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium.
  • Corman VM; These authors contributed equally to this work and share first authorship.
  • Donoso Mantke O; National Consultant Laboratory for Coronaviruses, Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • McCulloch E; These authors contributed equally to this work and share first authorship.
  • Lammens C; Quality Control for Molecular Diagnostics (QCMD), Glasgow, United Kingdom.
  • Goossens H; These authors contributed equally to this work and share first authorship.
  • Niemeyer D; Quality Control for Molecular Diagnostics (QCMD), Glasgow, United Kingdom.
  • Wallace PS; Department of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium.
  • Klapper P; Department of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium.
  • Niesters HG; National Consultant Laboratory for Coronaviruses, Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Drosten C; Quality Control for Molecular Diagnostics (QCMD), Glasgow, United Kingdom.
  • Ieven M; School of Biological Sciences, Division of Infection, Immunity and Respiratory Medicine, The University of Manchester, Manchester, United Kingdom.
Euro Surveill ; 25(27)2020 07.
Article in English | MEDLINE | ID: covidwho-845124
ABSTRACT
Laboratory preparedness with quality-assured diagnostic assays is essential for controlling the current coronavirus disease (COVID-19) outbreak. We conducted an external quality assessment study with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to support clinical laboratories with a proficiency testing option for molecular assays. To analyse SARS-CoV-2 testing performance, we used an online questionnaire developed for the European Union project RECOVER to assess molecular testing capacities in clinical diagnostic laboratories.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Coronavirus / Clinical Laboratory Techniques / Molecular Diagnostic Techniques / Pandemics Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: 1560-7917.ES.2020.25.27.2001223

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Coronavirus / Clinical Laboratory Techniques / Molecular Diagnostic Techniques / Pandemics Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: 1560-7917.ES.2020.25.27.2001223